Newsbenzinga
Zevra Therapeutics Submits U.S. Patent For MIPLYFFA To FDA For Listing In Orange Book Publication; Patent Expires On November 19, 2041
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…